CELC Stock Analysis: Buy, Sell, or Hold?
CELC - Celcuity Inc. Common Stock
$112.63
-0.30 (-0.27%)
▼
5d:
-1.9%
30d:
+0.4%
90d:
+12.92%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 13, 2026
Smart Money Accumulation
CELC is down 7.2% this week, but smart money is accumulating calls. Top strike: $140 2026-05-15 with 3,021 OI. Call ratio: 100% View Scanner →
Strength: 8.6/10
Get Alerted When CELC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CELC shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CELC shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: CELC is currently trading at $112.63, which is considered fair relative to its 30-day fair value range of $107.17 to $114.83.
Technical Outlook: Technically, CELC is in a uptrend. Immediate support is located at $100.01, while resistance sits at $118.97.
Market Sentiment: CELC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $128.60 (+14.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CELC is in a uptrend. Immediate support is located at $100.01, while resistance sits at $118.97.
Market Sentiment: CELC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $128.60 (+14.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$107.17 -
$114.83
Company Quality Score
56/100
(HOLD)
Options IV Signal
5th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
87.5%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 5th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($128.60)
Fair Price Analysis
30-Day Fair Range
$107.17 -
$114.83
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$12.34
(11.0%)
Support & Resistance Levels
Support Level
$100.01
Resistance Level
$118.97
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-102.39
Wall Street Target
$128.60
(+14.2%)
Share & Embed Analysis
Last updated: April 02, 2026 5:29 PM ET
Data refreshes hourly during market hours. Next update: 6:29 PM
Data refreshes hourly during market hours. Next update: 6:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
David Dalvey
SELL
20000 shares
2026-01-27
Richard E Buller
SELL
3000 shares
2025-12-05
Richard E Buller
SELL
3900 shares
2025-11-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 65 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 61 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 50 HOLD |
Advanced CELC Option Strategies
Professional options setups generated by AI based on today's CELC price and gamma walls.
